Roche, Chiasma ink deal on hormone disorder treatment (Reuters, 18 February 2013)

19 Feb 2013


Drugmakers Roche and Chiasma have announced plans to work together to develop and market an oral formulation of octreotide for patients with acromegaly.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story